Rush Copley Medical Center in Aurora, Illinois, is a 210-bed hospital in the greater Fox Valley area. It is named after Ira Clifton Copley, who donated over $2 million for the original hospital.

There are 210 beds in Rush - Copley Medical Center.

During the past decade, Rush - Copley Medical Center conducted 178 clinical trials. In the 10-year time frame, 178 clinical trials started and 114 clinical trials were completed, i.e. on average, 64% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 69 clinical trials were completed. i.e. 87.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush - Copley Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 144 trials, followed by "Alliance for Clinical Trials in Oncology" with 38 trials sponsored, "SWOG Cancer Research Network" with 36 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored and "NRG Oncology" with 22 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush - Copley Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 130 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Rush - Copley Medical Center" are "Recurrent Breast Carcinoma" (13 trials), "Invasive Breast Carcinoma" (12 trials), "Stage IV Breast Cancer AJCC v6 and v7" (12 trials), "Recurrent Ovarian Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (9 trials). Many other conditions were trialed in "Rush - Copley Medical Center" in a lesser frequency.

Most popular intervention types in "Rush - Copley Medical Center" are "Drug" (223 trials), "Other" (170 trials), "Biological" (114 trials), "Procedure" (66 trials) and "Radiation" (48 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (86 trials), "Quality-of-Life Assessment" (74 trials), "Questionnaire Administration" (47 trials), "Paclitaxel" (35 trials) and "Cisplatin" (33 trials). Other intervention names were less common.

The vast majority of trials in "Rush - Copley Medical Center" are 217 trials for "All" genders, 47 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Rush - Copley Medical Center". undefined are not yet recruiting, 74 are recruiting, 123 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in Rush - Copley Medical Center, 5 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Rush - Copley Medical Center, 12 "Phase 1" clinical trials were conducted, 140 "Phase 2" clinical trials and 139 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".